These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3833355)

  • 41. The therapeutic role of isosorbide-5-mononitrate+ in stable and unstable angina pectoris.
    Distante A; Lombardi M; Moscarelli E; Morales MA; L'Abbate A
    Z Kardiol; 1986; 75 Suppl 3():38-41. PubMed ID: 3541417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 43. [Isosorbide-5-mononitrate. A metabolite of isosorbide dinitrate].
    Aldershvile J; Abildgaard U
    Ugeskr Laeger; 1985 Jun; 147(24):1948-9. PubMed ID: 4024344
    [No Abstract]   [Full Text] [Related]  

  • 44. [Intraindividual dose-response relationship of sustained-release Elantan].
    Kenedi P
    Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isosorbide-5-mononitrate in angina pectoris.
    Poss M; Racicot D; Kiser WR
    Ann Intern Med; 1994 Oct; 121(7):547. PubMed ID: 8093205
    [No Abstract]   [Full Text] [Related]  

  • 46. Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning.
    Rinaldi CA; Linka AZ; Masani ND; Avery PG; Jones E; Saunders H; Hall RJ
    Circulation; 1998 Aug; 98(8):749-56. PubMed ID: 9727544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The antianginal effect of isosorbide mononitrate.
    Bassan M
    Am J Cardiol; 1994 Jul; 74(1):103. PubMed ID: 8017298
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study.
    Lombardi M; Morales MA; Michelassi C; Moscarelli E; Distante A; L'Abbate A
    Eur Heart J; 1993 Jun; 14(6):845-51. PubMed ID: 8325315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NO-donors and angina pectoris: more than just symptomatic treatment?
    Cleophas TJ; Niemeyer MG
    Neth J Med; 1997 Apr; 50(4):180-3. PubMed ID: 9130843
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease].
    Sizova ZM; Kozlova NV; Zakharova VL; Shameeva ES
    Kardiologiia; 2015; 55(2):10-5. PubMed ID: 26164982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effectiveness of isosorbide dinitrate and pentaerythritol tetranitrate by means of acute determination of the coronary reserve on cycloergometer in patients with stable angina pectoris].
    Poprawski K
    Pol Arch Med Wewn; 1979 Sep; 62(3):221-9. PubMed ID: 523326
    [No Abstract]   [Full Text] [Related]  

  • 52. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries.
    Bugiardini R; Borghi A; Pozzati A; Ottani F; Morgagni GL; Puddu P
    Am J Cardiol; 1993 Aug; 72(3):343-7. PubMed ID: 8342515
    [No Abstract]   [Full Text] [Related]  

  • 53. Effectiveness of modified release isosorbide mononitrate affected by incorrect use.
    Hider JD; Shehab Z; Courteney-Harris R
    BMJ; 2000 Feb; 320(7233):483. PubMed ID: 10678861
    [No Abstract]   [Full Text] [Related]  

  • 54. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
    Schiavoni G; Bosimini E; Amico C
    Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of isosorbide dinitrate and nicardipine hydrochloride on postprandial blood pressure in elderly patients with stable angina pectoris or healed myocardial infarction.
    Connelly CM; Waksmonski C; Gagnon MM; Lipsitz LA
    Am J Cardiol; 1995 Feb; 75(4):291-3. PubMed ID: 7832144
    [No Abstract]   [Full Text] [Related]  

  • 56. Isosorbide and isorbide dinitrate.
    Buckley EG; Shields MB
    Am J Ophthalmol; 1980 Mar; 89(3):457. PubMed ID: 7369307
    [No Abstract]   [Full Text] [Related]  

  • 57. Monitoring medical management of coronary artery disease: patient selection, optimal management, and potential problems for diagnosis.
    Cerqueira MD
    J Nucl Cardiol; 2000; 7(4):392-4. PubMed ID: 10958283
    [No Abstract]   [Full Text] [Related]  

  • 58. [Correlation of the anti-angina effect of nitrosorbide in patients with stenocardia of effort following a single dose and a course of treatment].
    Arifdzhanova UA; Kostko SZ; Vakhidova MA; Trigulova RKh; Kasymkhodzhaev ASh
    Kardiologiia; 1987 Dec; 27(12):93-4. PubMed ID: 3444227
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
    Distante A; Lombardi M; Moscarelli E; Morales MA; Sabino F; L'Abbate A
    Z Kardiol; 1985; 74 Suppl 4():25-31. PubMed ID: 4096068
    [No Abstract]   [Full Text] [Related]  

  • 60. Eccentric dosing and exercise time.
    Klein HO
    Am J Cardiol; 1994 Jul; 74(1):103. PubMed ID: 8017297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.